Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGüner, Ahmet
dc.contributor.authorZehir, Regayip
dc.contributor.authorKalçık, Macit
dc.contributor.authorUslu, Abdulkadir
dc.contributor.authorÖsken, Altuğ
dc.contributor.authorKalkan, Ali Kemal
dc.contributor.authorGültekin Güner, Ezgi
dc.date.accessioned2021-11-01T15:02:56Z
dc.date.available2021-11-01T15:02:56Z
dc.date.issued2019
dc.identifier.citationGüner, A., Zehİr, R., KalçIk, M., Uslu, A., Ösken, A., Kalkan, A. K., & Güner, E. G. (2020). Eosinophil percentage as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Interventional Medicine and Applied Science, 11(3), 146-153.en_US
dc.identifier.issn2061-1617
dc.identifier.issn2061-5094
dc.identifier.urihttps://doi.org/10.1556/1646.11.2019.17
dc.identifier.urihttps://hdl.handle.net/11491/6869
dc.description.abstractBackground: In addition to proinflammatory properties, eosinophils can stimulate platelet activation and enhance prothrombotic pathways. In this study, we aimed to investigate the association between the eosinophil percentage (EOS%) and major adverse cardiac events (MACE) in patients with ST-segment elevation myocardial infarction (STEMI). Methods: This study enrolled a total of 1,909 patients who were diagnosed with STEMI. Ventricular arrhythmia, reinfarction, the need for cardiopulmonary resuscitation, target vessel revascularization, congestive heart failure, and cardiovascular mortality during index hospitalization were defined as MACE. Results: Three hundred and eighty patients (19.7%) reached the combined endpoint with MACE. The rates of inhospital mortality and MACE were significantly higher in low EOS% group as compared to high EOS% group (4% vs. 1.1%, p < 0.01 and 32.8% vs. 11.3%, p < 0.01, respectively). On multivariate logistic regression analyses, EOS% (OR = 0.44, p < 0.01) was found to be one of the independent predictors of MACE. The EOS% lower than 0.60 on admission predicted inhospital MACE with a sensitivity of 68% and a specificity of 72% (AUC: 0.684, p < 0.01). Conclusions: Low EOS% on admission may be associated with high inhospital MACE in STEMI patients. EOS% may be used as a novel biomarker for risk stratification of these patients.en_US
dc.language.isoengen_US
dc.publisherAkademiai Kiado Zrten_US
dc.relation.ispartofInterventional Medicine And Applied Scienceen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectComplete Blood Countsen_US
dc.subjectEosinophil Percentageen_US
dc.subjectInflammationen_US
dc.subjectMajor Adverse Cardiac Eventsen_US
dc.subjectMyocardial Infarctionen_US
dc.titleEosinophil percentage as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionen_US
dc.typearticleen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.identifier.volume11en_US
dc.identifier.issue3en_US
dc.identifier.startpage146en_US
dc.identifier.endpage153en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Guner, Ahmet; Uslu, Abdulkadir] Kartal Kosuyolu Training & Res Hosp, Dept Cardiol, Istanbul, Turkey; [Zehir, Regayip; Osken, Altug] Siyami Ersek Thorac & Cardiovasc Surg Training &, Dept Cardiol, Istanbul, Turkey; [Kalcik, Macit] Hitit Univ, Fac Med, Dept Cardiol, Buhara 25 Sok 1,A Daire 22, Corum, Turkey; [Kalkan, Ali Kemal; Guner, Ezgi Gultekin] Mehmet Akif Ersoy Thorac & Cardiovasc Surg Traini, Dept Cardiol, Istanbul, Turkeyen_US
dc.contributor.institutionauthorKalçık, Macit
dc.identifier.doi10.1556/1646.11.2019.17
dc.authorwosidÖsken, Altuğ / AAW-7198-2021
dc.description.wospublicationidWOS:000576384300004en_US
dc.description.scopuspublicationid2-s2.0-85094136401en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster